clinical trial · NCT06284876
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
Il-Yang Pharm. Co., Ltd.·phase3·active not recruiting·n = 416
Peptic UlcerIlaprazoleLansoprazoleIlaprazole PlaceboLansoprazole Placebo
brief summary
To demonstrate the non-inferiority of Ilaprazole 10 mg to the active control in prevention of NSAIDs-associated peptic ulcer, as assessed by the proportion of subjects with peptic ulcer by Week 24
started
Jul 23, 2024
primary completion
Aug 30, 2027
completion
Feb 28, 2028
last updated
Nov 6, 2026
detailed description
Not provided
official title
A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol